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Abstract
Background
Helminth infections can negatively affect the immunologic host control, which may increase
the risk of progression from latent Mycobacterium tuberculosis infection to tuberculosis (TB)
disease and alter the clinical presentation of TB. We assessed the prevalence and deter-
mined the clinical relevance of helminth co-infection among TB patients and household con-
tact controls in urban Tanzania.
Methodology
Between November 2013 and October 2015, we enrolled adult (18 years) sputum smear-
positive TB patients and household contact controls without TB during an ongoing TB cohort
study in Dar es Salaam, Tanzania. We used Baermann, FLOTAC, Kato-Katz, point-of-care
circulating cathodic antigen, and urine filtration to diagnose helminth infections. Multivariable
logistic regression models with and without random effects for households were used to
assess for associations between helminth infection and TB.
Principal findings
A total of 597 TB patients and 375 household contact controls were included. The median
age was 33 years and 60.2% (585/972) were men. The prevalence of any helminth infec-
tion among TB patients was 31.8% (190/597) and 25.9% (97/375) among controls. Stron-
gyloides stercoralis was the predominant helminth species (16.6%, 161), followed by
hookworm (9.0%, 87) and Schistosoma mansoni (5.7%, 55). An infection with any hel-
minth was not associated with TB (adjusted odds ratio (aOR) 1.26, 95% confidence
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interval (CI): 0.88–1.80, p = 0.22), but S. mansoni infection was (aOR 2.15, 95% CI: 1.03–
4.45, p = 0.040). Moreover, S. mansoni infection was associated with lower sputum bacte-
rial load (aOR 2.63, 95% CI: 1.38–5.26, p = 0.004) and tended to have fewer lung cavita-
tions (aOR 0.41, 95% CI: 0.12–1.16, p = 0.088).
Conclusions/Significance
S. mansoni infection was an independent risk factor for active TB and altered the clinical pre-
sentation in TB patients. These findings suggest a role for schistosomiasis in modulating the
pathogenesis of human TB. Treatment of helminths should be considered in clinical man-
agement of TB and TB control programs.
Author summary
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, and parasitic
worm infections are typical diseases of poverty. They often overlap geographically, and
can occur in the same individual. Parasitic worm infections contribute to the down-regu-
lation of the essential immune response against TB, and therefore can increase progres-
sion from latent M. tuberculosis infection to active TB. We conducted a case-control study
in Dar es Salaam, the economic capital of Tanzania, where TB and helminths constitute a
considerable burden. We found that infection with the blood fluke Schistosoma mansoni
was associated with active TB, while none of the other parasitic worms showed such an
association. Interestingly, TB patients infected with S. mansoni had significantly lower
sputum bacterial load at diagnosis and tended to have fewer lung cavitations compared
with TB patients without any parasitic worm infection. Diagnosis and treatment of para-
sitic worm infections, particularly schistosomiasis, should be considered during the man-
agement of TB patients and in the context of TB control programs. This could help to
reduce the TB burden in settings where TB and parasitic worms co-exist.
Introduction
Tuberculosis (TB), caused by Mycobacterium tuberculosis remains a challenging disease to con-
trol. Indeed, over two billion people are estimated to be infected with M. tuberculosis world-
wide [1]. Moreover one billion people are infected with soil-transmitted helminths,
schistosomes, filarial worms, and food-borne trematodes [2–4]. In 2014, an estimated 9.6 mil-
lion new TB patients were notified and 1.5 million TB patients died from the disease [1]. TB is
a leading cause of deaths from an infectious disease [5].
TB and helminthiases overlap geographically, particularly in areas where poverty persists,
for example in countries of sub-Saharan Africa [1,6]. Where TB and helminth infections co-
occur, they can affect the same individual and thus exacerbate the course of disease [6]. Several
conditions such as diabetes mellitus, malnutrition, and malignancies are known to increase
the risk of progressing from latent M. tuberculosis infection to active TB [7]. Human immuno-
deficiency Virus (HIV)-induced immunodeficiency is by far the most important risk factor for
developing TB [1,8], but parasitic co-infections such as with helminths can also contribute to
the development of TB [9–11]. Immune dysregulations caused by helminth infections are
known to negatively affect the prognosis of HIV and malaria [6,12]. The immune response to
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helminth infections is characterized by the induction of CD4+ T-helper 2 (Th2) and down-reg-
ulation of CD4+ T-helper 1 (Th1) cells [12–15]. This immunological imbalance has been sug-
gested to increase the risk of progression from latent M. tuberculosis infection to active TB and
to worsen the clinical outcomes.
We aimed to study the interaction between TB and helminth co-infections by comparing
the prevalence of helminth infections, using a suite of diagnostic techniques, between TB
patients and household contact controls without TB in an ongoing cohort study in Dar es
Salaam, Tanzania, and to assess the effects of helminth infection on the clinical presentation
and outcomes of TB disease.
Methods
Ethics statement
The study protocol was approved by the institutional review board of the Ifakara Health Insti-
tute (IHI; reference no. IHI/IRB/No 04–2015) and the Medical Research Coordinating Com-
mittee of the National Institute of Medical Research (NIMR; reference no. NIMR/HQ/R.8c/
Vol.I/357) in Tanzania, and the ethics committee of north-west and central Switzerland
(EKNZ; reference no.: UBE-15/42). Written informed consent was obtained from all study
participants. TB patients were treated according to the National TB and Leprosy Programme
(NTLP) treatment guideline [8]. Individuals with a Schistosoma spp. infection were treated
with praziquantel (40 mg/kg). Other helminth infections were treated with albendazole (400
mg) immediately after diagnosis, as recommended by the national treatment guidelines [16].
HIV-positive patients were clinically managed according to the Tanzania National HIV and
acquired immune deficiency syndrome (AIDS) treatment guideline [17].
Study setting
The study was conducted in the densely populated urban setting of Temeke district in Dar es
Salaam, which is the economic capital of Tanzania. The population of Temeke is estimated at
1.4 million. In 2014, about one third of all TB patients from Dar es Salaam were notified in
Temeke district (4,373; 32%) [18]. The overall HIV prevalence in the general adult population
in Dar es Salaam is 5.2% [19]. The study area includes two TB sub-districts, Wailes I and
Wailes II, whose patients are clinically managed at the Temeke district hospital and the two
associated TB diagnostic and treatment centers of Tambukareli and Pasada [20].
Study design
The study was conducted within the frame of an ongoing prospective cohort study of TB
patients and household contact controls in Dar es Salaam (TB-DAR). We assessed the associa-
tion of TB and helminth infection in a case-control study design of TB patients (sputum
smear-positives for acid-fast bacilli [AFB]) and household contact controls (Xpert MTB/RIF
negative), who were matched by age (±5 years) and whenever possible by sex. We prospectively
followed-up TB patients and assessed the clinical outcomes comparing TB patients with and
without helminth infection at 6 and 12 months after recruitment.
Study population and sample size
We consecutively enrolled study participants starting in November 2013 until October 2015 to
reach the required sample size. Over this period, we included adult TB patients (18 years of
age and sputum-smear positive) and household contact controls. Any individual living in the
same household as the index TB patients enrolled in the study is referred to as a household
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contact control. Controls at recruitment were free of symptoms and signs suggestive of TB,
healthy on physical examination, and had a negative Xpert MTB/RIF result (Cepheid; Califor-
nia, United States of America).
Assuming a helminth prevalence of 45% in TB patients and 26% in controls based on results
from previous publications [21] and a power of 80%, the target sample size was 109 study par-
ticipants (for each group) to detect a prevalence difference of 19% between the two groups
with a significance level of test 0.05, two-tailed and calculated with Stata version 14.0 (Stata
Corp; Texas, United States of America).
Study procedures
TB patients and household contact controls were interviewed and underwent physical exami-
nation during recruitment at the study site (see under “Data Collection and Definitions”). We
collected skinfold measurements from four body sites (biceps, triceps, subscapular, and suprai-
liac) using the Harpenden skinfold caliper [22]. The percentage body fat was calculated as pre-
viously described [23]. Household contacts with no symptoms or signs of TB submitted a
sputum sample for Gene Xpert MTB/RIF to rule-out TB. We collected blood, stool, and urine
samples from TB patients and controls for subsequent laboratory investigations. Chest X-rays
for TB patients were done at the Temeke district hospital and were interpreted by an experi-
enced board certified radiologist who was blinded to patients’ clinical data. Trained field work-
ers collected geographic coordinates (global positioning system [GPS]) from the patients’
homes using Samsung Tab 4 android tablets (Samsung; Suwon, South Korea).
Laboratory procedures
Microbiological investigations. A patient was considered as having TB when any of the
two submitted sputum samples were positive for AFB by staining sputum smears using the
Ziehl-Nielsen (ZN) method, and a positive mycobacterial culture. Sputum smear microscopy
was done at the Temeke district hospital under continuous quality control by the central tuber-
culosis reference laboratory (Dar es Salaam, Tanzania). AFB smear-positive results were
graded according to World Health Organization/International Union Against Tuberculosis
and Lung Disease (WHO/IUATLD) guidelines: “scanty” with 1–9 AFB per 100 oil immersion
fields; “1+” with 10–99 AFB per 100 immersion fields; “2+” with 1–10 AFB per 1 immersion
field, and “3+” with>10 AFB per immersion field [8,24]. To rule out TB among household
controls, an additional sputum sample from TB patients and controls was sent to the TB labo-
ratory at the Bagamoyo Research and Training Center (BRTC), IHI, for GeneXpert MTB/RIF
(controls) and for culture on Lo¨wenstein-Jensen media (TB patients and controls).
Helminthological investigations. For the diagnosis of helminth infections, single stool
and urine samples were collected from each participant before the start of TB treatment (TB
patients) and at the time of enrolment (controls). All stool and urine samples were transferred
to the Helminth Unit at BRTC and examined for helminth infections using standardized, qual-
ity-controlled procedures as described elsewhere [25–27]. The Kato-Katz (triplicate thick
smears per stool sample) and the FLOTAC methods were used to diagnose Ascaris lumbricoides,
hookworm, S. mansoni, and Trichuris trichiura infections. The Baermann method was used to
identify Strongyloides stercoralis infections [28]. The adhesive tape test was used to diagnose
Enterobius vermicularis infections [26]. In addition, a rapid point-of-care circulating cathodic
antigen (POC-CCA) urine cassette test was employed for the diagnosis of S. mansoni [29]. The
urine filtration method was applied to detect S. haematobium infections [26]. For quality con-
trol, 10% of Kato-Katz slides were randomly selected and re-examined by a second reader.
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Blood testing. In line with national HIV testing algorithms, screening was done using the
Alere Determine HIV rapid test (Alere, USA). The Uni-gold HIV (Trinity Biotech; Wicklow,
Ireland) rapid test served as a confirmatory test in case of a positive screening test. The CD4+
T-cells counts were determined using a FACSCount machine (Becton Dickinson Biosciences;
California, United States of America). A full blood cell count was done with a MS4 Vet hema-
tology analyzer (Diamond Diagnostics; Massachusetts, United States of America). All blood
tests were performed at the Temeke district hospital laboratory, which is under supervision
and quality control by the regional laboratory technician.
Data collection and definitions
We collected socio-demographic indicators including age, sex, ethnicity, education, and
household income. Anthropometric data included weight, height, and skinfold measurements.
Clinical data collected pertained to presenting symptoms of TB patients, TB treatment cate-
gory, and treatment outcomes. Laboratory data included ZN sputum smear results and Gene
Xpert MTB/RIF results, helminth species infections, HIV status, full blood cell count, and
CD4+ cell count. All study participants were asked about their use of anthelmintic treatment in
the last 12 months prior to the enrollment into the study. Study data were captured by elec-
tronic case report forms using the open-source data collection software ODK on Android PC
tablets [30]. Data management was done using the eManagement tool “odk_planner”, as previ-
ously described [30]. Data were uploaded to a password protected secure server with regular
back-ups.
In order to grade the clinical severity of TB, we adopted a previously published clinical TB
score [31], with the following modification: 12 points TB score parameters instead of 13 points
as tachycardia was not systematically measured. The following TB score parameters were used:
(i) coughing; (ii) hemoptysis; (iii) chest pain; (iv) dyspnea; (v) night sweating; (vi) anemic con-
junctivae; (vii) positive finding at auscultation; (viii) axillary temperature >37.0˚C; (ix) mid
upper arm circumference (MUAC) <220 mm; (x) MUAC <200 mm; (xi) body mass index
(BMI) <18 kg/m2; and (xii) BMI<16 kg/m2. TB score was then categorized into mild (score
of 1–5) and severe (score of6). Low BMI was defined as BMI<18 kg/m2; high sputum bacte-
rial load as AFB sputum smear result2+ (quantitative scoring), which correlates with Gen-
eXpert Ct values [32]. To assess the clinical outcomes among TB patients, we defined poor
gain as a change in absolute body weight (<7 and7 kg), BMI (<2.6 and2.6 kg/m2) and
body fat (<0 and0%) from recruitment to month 6 of follow-up.
“Any helminth infection” was defined as infection with any of the following helminth spe-
cies: A. lumbricoides, E. vermicularis, hookworm, Hymenolepis diminuta, S. haematobium, S.
mansoni, S. stercoralis and T. trichiura. High occupational risk for schistosomiasis was defined
as working in rice fields, sand harvesting, washing cars, and fishing in freshwater. The intensity
of helminth infection was defined according to WHO classification [33]. The average egg
counts from the triplicate Kato-Katz thick smears per stool sample and per individual were
multiplied by a factor of 24 to obtain eggs per gram (EPG) of stool [25].
Statistical analysis
We compared the characteristics of TB patients and household contact controls at the time of
TB diagnosis or enrolment. The prevalence of helminth infection was calculated from the gen-
eralized estimations equation adjusting for clustering at the household level. We used multi-
level mixed-effects logistic regression with random intercepts at the level of households to
assess risk factors for helminth infection. To assess risk factors for TB, we compared cases and
controls using unconditional logistic regression because not all TB cases could be assigned a
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control. In addition, we also performed conditional logistic regression among matched pairs
to confirm the results. Additional analyses assessed the association of TB and with specific hel-
minth species separately. We also examined whether the association between the presence of a
helminth infection and a recent history of deworming drugs depended on HIV infection status
by including an interaction term in the logistic regression model. Among TB patients, logistic
regression models were used to study associations between helminth infection and clinical pre-
sentation at the time of TB diagnosis (such as TB score, high sputum bacterial load, lung infil-
tration, and cavitation), and to study the association between helminth infection and clinical
outcomes after 6 months of TB treatment (change in absolute weight, BMI, and percentage
body fat). Associations were expressed as crude odds ratios (ORs) and adjusted ORs (aORs).
All analyses were performed in Stata version 14.0 (Stata Corp; Texas, United States of
America).
We used the geographic coordinates of the TB patients’ homes to analyze the spatial distri-
bution of TB and helminth co-infections. The prevalence of helminths and helminth species
was analyzed at the ward level for optimal readability. The average area per ward in the Dar es
Salaam region is 15.5 km2 [19]. The maps were produced using the software package ArcGIS
Desktop version 10.2 (ESRI; California, United States of America) and the shape files from the
National Bureau of Statistics of Tanzania [34].
Results
Characteristics of study participants
A total of 597 TB patients and 375 household contact controls were included. Table 1 summa-
rizes the socio-demographic and clinical characteristics of TB patients and controls. The study
participants’ flow diagram is shown in Fig 1. Among all study participants, the median age was
33 years (interquartile range [IQR]: 26–41 years) and 60.2% (585/972) were men. HIV preva-
lence was 20.4% (95% confidence interval (CI): 17.9–23.0%). TB patients were more frequently
male compared with controls (68.8% [411/597] vs. 46.4% [174/375]), HIV-positive (27.3%
[163] vs. 9.3% [35]), and smokers (18.1% [108] vs. 8.8% [33]). TB patients also had a lower
median BMI (18.3 kg/m2, IQR: 16.5–20.4 kg/m2 vs. 23.9 kg/m2, IQR: 21.6–28.1 kg/m2) and a
lower median hemoglobin level (11.3 g/dl, IQR: 9.9–12.7 g/dl vs. 12.8 g/dl, IQR: 11.5–14.1
g/dl). The patient characteristics, stratified by HIV status, are shown in S1 Table.
Prevalence and risk factors for helminth infection
Among all participants, the prevalence of any helminth infection was 29.5% (95% CI: 26.7–
32.6%). S. stercoralis (16.5%, 161) was the predominant helminth species, followed by hook-
worm (9.0%, 87), S. mansoni (5.7%, 55) and S. haematobium (2.0%, 19). Overall, TB patients
were more frequently co-infected with any helminth species compared with controls (OR 1.34,
95% CI: 1.00–1.78, p = 0.048; Table 2). The prevalence of helminth infection was lower in
HIV-positive (22.7%, 45) compared with HIV-negative study participants (31.3%, 242; S1
Table). Similarly, helminth infection was lower among TB patients co-infected with HIV
(22.7%, 37) compared with HIV-negative TB patients (35.3%, 153; S2 Table). We found that
most study participants had light-intensity helminth infection. For example, 96.4% (54) of
study participants had light-intensity hookworm infection as determined by the Kato-Katz
method (S3 Table). The prevalence and geographic distribution of species-specific helminth
infections in the study area is shown in S1 Fig.
Study participants with occupational risk for acquiring schistosomiasis, such as working in
rice fields, sand harvesting, washing cars, and fishing had higher odds of being infected with
any helminth species (aOR 1.42, 95% CI: 1.04–1.95, p = 0.029). HIV-positive patients were less
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Table 1. Socio-demographic and clinical characteristics of tuberculosis (TB) patients and household contact controls without TB.
Characteristics Total
(n = 972)
TB patient
(n = 597)
Controls
(n = 375)
Age in years, median (IQR) 33 (26–41) 33 (26–40) 33 (26–42)
Age groups (years)
18–24 194 (20.0) 107 (17.9) 87 (23.2)
25–34 347 (35.7) 226 (37.9) 121 (32.3)
35–44 266 (27.4) 169 (28.3) 97 (25.9)
45 165 (17.0) 95 (15.9) 70 (18.7)
Sex
Female 387 (39.8) 186 (31.2) 201 (53.6)
Male 585 (60.2) 411 (68.8) 174 (46.4)
HIV status
Negative 774 (79.6) 434 (72.7) 340 (90.7)
Positive 198 (20.4) 163 (27.3) 35 (9.3)
Education level
No/primary 806 (82.9) 500 (83.8) 306 (81.6)
Secondary/University 166 (17.1) 97 (16.2) 69 (18.4)
Occupation
Unemployed 349 (35.9) 204 (34.2) 145 (38.7)
Employed 623 (64.1) 393 (65.8) 230 (61.3)
Smoking status
No 831 (85.5) 489 (81.9) 342 (91.2)
Yes 141 (14.5) 108 (18.1) 33 (8.8)
People in the household
3 731 (75.2) 442 (74.0) 289 (77.1)
>3 241 (24.8) 155 (26.0) 86 (22.9)
Household income per month (US$)
100 763 (78.5) 473 (79.2) 290 (77.3)
>100 209 (21.5) 124 (20.8) 85 (22.7)
Body weight at diagnosis, [in kg], (IQR) 54 (48–61) 51 (46–57) 59 (53–67)
BMI (kg/m2), median (IQR) 20.0 (17.6–23.4) 18.3 (16.6–20.4) 23.9 (21.6–28.1)
BMI categories (kg/m2)
Underweight <18.5 337 (34.7) 318 (53.3) 19 (5.1)
Normal, 18.5–24.9 454 (46.7) 256 (42.9) 198 (52.8)
Overweight 25.0–29.9 119 (12.2) 21 (3.5) 98 (26.1)
Obese30 62 (6.4) 2 (0.3) 60 (16.0)
Body fat (%) 10.1 (7.7–14.7) 9.5 (6.8–13.7) 11.5 (8.5–17.0)
MUAC (cm), median (IQR) 24.3 (22.7–26.2) 23.3 (22.0–25.3) 25.3 (23.7–28.0)
Waist hip ratio, median (IQR) 0.89 (0.86–0.94) 0.89 (0.86–0.94) 0.89 (0.86–0.94)
Occupational riska
No 521 (54.2) 322 (54.2) 199 (54.1)
Yes 441 (45.8) 272 (45.8) 169 (45.9)
Individual deworming (past 12 months)
Yes 797 (82.0) 484 (81.1) 313 (83.5)
No 175 (18.0) 113 (18.9) 62 (16.5)
Hb level (g/dl), median (IQR) 12 (10.4–13.3) 11.3 (9.9–12.7) 12.8 (11.5–14.1)
a Occupational risk for acquiring schistosomiasis (working in rice fields, sand harvesting, washing cars, and fishing)
BMI, body mass index; HIV, human immunodefiency virus; Hb, hemoglobin level; IQR, inter-quartile range; MUAC, mid-upper arm circumference; US$,
United States dollars (1 US$ = 2,190 Tanzanian Shillings in March 2016)
doi:10.1371/journal.pntd.0005342.t001
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Fig 1. Study participants’ flow diagram.
doi:10.1371/journal.pntd.0005342.g001
Table 2. Frequency distribution of helminth infections, stratified by TB patients and household contact controls.
Helminth infection All TB patients Controls Comparing TB patients and controlsa
(n = 972) (n = 597) (n = 375)
n (%) n (%) n (%) OR (95% CI) p-value
Any helminth 287 (29.5) 190 (31.8) 97 (25.9) 1.34 (1.00–1.78) 0.048
Helminth species
Strongyloides stercoralis 161 (16.6) 111 (18.6) 50 (13.3) 1.48 (1.03–2.13) 0.032
Hookworm 87 (9.0) 55 (9.2) 32 (8.5) 1.09 (0.69–1.72) 0.72
Ascaris lumbricoides 6 (0.6) 3 (0.5) 3 (0.8) 0.63 (0.13–3.12) 0.57
Enterobius vermicularis 5 (0.5) 1 (0.2) 4 (1.1) NA NA
Trichuris trichiura 9 (0.9) 6 (1.0) 3 (0.8) 1.25 (0.31–5.06) 0.75
Hymenolepis diminuta 2 (0.2) 1 (0.2) 1 (0.3) NA NA
Schistosoma spp. 70 (7.2) 49 (8.2) 21 (5.6) 1.51 (0.89–2.56) 0.13
Schistosoma mansoni 55 (5.7) 40 (6.7) 15 (4.0) 1.72 (0.94–3.17) 0.079
Schistosoma haematobium 19 (2.0) 11 (1.8) 8 (2.1) 0.86 (0.34–2.16) 0.75
Helminth infection 0.13
None 685 (70.5) 407 (68.2) 278 (74.1) 1
Mono-infection 237 (24.4) 158 (26.5) 79 (21.1) 1.37 (1.00–1.86)
Infection with2 species 50 (5.1) 32 (5.3) 18 (4.8) 1.21 (0.67–2.21)
a Estimates from an unadjusted mixed-effect models with household as a random intercept
NA, not applicable; OR, odds ratio
doi:10.1371/journal.pntd.0005342.t002
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likely to be infected with any helminth species (aOR 0.57, 95% CI: 0.37–0.87, p = 0.010;
Table 3). Study participants who did not take anthelmintic treatment in the past 12 months
did not have significant higher odds of being co-infected with any helminth species (aOR 1.35,
95% CI: 0.92–1.99, p = 0.12). There was no statistically significant interaction between the
Table 3. Risk factors for any helminth infection among TB patients and household controls without TB.
Characteristic Helminth infection, n (%) Unadjusted Adjusted
Yes No OR (95% CI) p-value aOR (95% CI) p-value
Participant 0.054 0.18
Controls 97 (33.8) 278 (40.6) 1.00 1.00
TB patients 190 (66.2) 407 (59.4) 1.35 (1.00–1.82) 1.29 (0.88–1.87)
Age group (years) 0.30 0.46
18–24 50 (17.4) 144 (21.0) 1.00 1.00
25–34 115 (40.1) 232 (33.9) 1.46 (0.96–2.23) 1.38 (0.89–2.17)
35–44 75 (26.1) 191 (27.9) 1.13 (0.72–1.78) 1.11 (0.68–1.82)
45 47 (16.4) 118 (17.2) 1.16 (0.70–1.92) 1.18 (0.69–2.03)
Sex 0.003 0.24
Female 93 (32.4) 294 (42.9) 1.00 1.00
Male 194 (67.6) 391 (57.1) 1.60 (1.17–2.18) 1.23 (0.87–1.75)
HIV status 0.022 0.010
Negative 242 (84.3) 532 (77.7) 1.00 1.00
Positive 45 (15.7) 153 (22.3) 0.63 (0.43–0.94) 0.57 (0.37–0.87)
BMI category (kg/m2) 0.077 0.47
BMI18 175 (61.0) 460 (67.2) 1.00 1.00
BMI <18 112 (39.0) 225 (32.8) 1.32 (0.97–1.79) 1.14 (0.79–1.64)
Education level 0.28 0.50
No/primary 243 (84.7) 563 (82.2) 1.00 1.00
Secondary/University 44 (15.3) 122 (17.8) 0.80 (0.53–1.20) 0.86 (0.55–1.34)
Employment status 0.13 0.42
Unemployed 93 (32.4) 256 (37.4) 1.00 1.00
Employed 194 (67.6) 429 (62.6) 1.28 (0.93–1.76) 1.16 (0.81–1.65)
Number of people in the household 0.66 0.97
3 218 (76.0) 69 (24.0) 1.00 1.00
>3 513 (74.9) 172 (25.1) 0.93 (0.65–1.32) 0.99 (0.69–1.42)
Household income per month (US$) 0.47 0.75
100 229 (79.8) 534 (78.0) 1.00 1.00
>100 58 (20.2) 151 (22.0) 0.87 (0.60–1.26) 0.94 (0.63–1.40)
Individual deworming (past 12 months) 0.043 0.12
Yes 224 (78.0) 573 (83.6) 1.00 1.00
No 63 (22.0) 112 (16.4) 1.48 (1.01–2.15) 1.35 (0.92–1.99)
Occupational riska 0.009 0.029
No 136 (47.7) 385 (56.9) 1.00 1.00
Yes 149 (52.3) 292 (43.1) 1.50 (1.11–2.03) 1.42 (1.04–1.95)
a Occupational risk for acquiring schistosomiasis (working in rice fields, sand harvesting, washing cars, and fishing)
BMI, body mass index; HIV, human immunodeficieny virus; US$, United States dollars (1 US$ = 2,190 Tanzanian Shillings in March 2016)
Multilevel mixed-effects logistic regression model with household as a random intercept, adjusted for TB status, age-groups, sex, HIV status, BMI,
education level, employment status, number of people living in the same household, individual deworming status, occupational risk, and income level.
Note: interaction between the effect of HIV and deworming status on the risk for any helminth infection: p = 0.50
doi:10.1371/journal.pntd.0005342.t003
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effects of HIV infection and deworming status on TB incidence (P-value from test for interac-
tion: 0.5). When analyzing the risk factors for helminth infection separately for TB patients
and household controls without TB, we found similar results (see S5 and S6 Tables).
Helminth infection as a risk factor for TB
Multiple logistic regression models adjusted for patient characteristics and known risk factors
for TB showed that any helminth infection was not statistically significantly associated with TB
(aOR 1.26, 95% CI: 0.88–1.80, p = 0.22, Table 4 and S7 Table). However, when analyzing each
helminth species separately, we found that S. mansoni infection was significantly associated
with TB (aOR 2.15, 95% CI: 1.03–4.45, p = 0.040), but there was no significant association
between TB and S. stercoralis or hookworm infection (S8 Table). Other co-factors that were
significantly associated with TB included: male sex, HIV co-infection, smoking, living in a
household with3 people, and a low BMI (Table 4). The unadjusted and adjusted ORs for any
helminth infection and S. mansoni are shown in S7 Table. Results were more pronounced
when using a conditional logistic regression model (S9 Table).
Effect of helminth infection on clinical presentation and disease severity
in TB patients
TB patients co-infected with any helminth infection were more likely than helminth un-
infected TB patients to present with hemoptysis (74 [38.9%] vs. 123 [30.2%]), had higher
median hemoglobin levels (11.7 g/dl, IQR: 10.1–13.0 g/dl vs. 11.3 g/dl, IQR: 9.8–12.5 g/dl) and
higher median eosinophil counts (0.2, IQR: 0.1–0.4 cells/μl vs. 0.1, IQR: 0.05–0.2 cells/μl;
Table 5). TB patients co-infected with S. mansoni were more likely to have lower sputum bacte-
rial load than helminth-uninfected TB patients (aOR 2.63; 95% CI: 1.38–5.26, p = 0.004). Fur-
thermore, we found that TB patients co-infected with S. mansoni tended to have fewer lung
cavities, although this association lacked statistical significance (aOR 0.41, 95% CI: 0.12–1.16,
p = 0.088; Table 6). There were no statistically significant differences in radiological features
between TB patients with and without any helminth infection as shown in S10 Table.
Effect of helminth infection on clinical outcomes in TB patients
Overall, 81.7% (273 TB patients) were cured at the end of TB treatment (at 6 months), 17.4%
(58) completed treatment (AFB smear results not available at 6 months, but documented com-
pletion of treatment), and 0.9% (3) were treatment failures (positive AFB smear result at 6
months). We found no significant associations between helminth infection (at time of recruit-
ment) and poor gain in absolute weight (aOR 0.89, 95% CI: 0.55–1.45, p = 0.63), BMI (aOR
0.74, 95% CI: 0.46–1.21, p = 0.23), and body fat percentage (aOR 0.92, 95% CI: 0.55–1.56,
p = 0.78) after 6 months on TB treatment, as shown in S11 Table.
Discussion
We present findings on the prevalence and association of TB and helminth co-infection
among adult TB patients and household contact controls in a highly-urbanized setting of Dar
es Salaam, Tanzania. We found that S. mansoni infection was a risk factor for TB disease. This
association remained significant after adjustment for other known risk factors for TB, such as
HIV infection, smoking, and underweight [35]. None of the other investigated helminth spe-
cies or the surrogate measure of “any helminth infection” were significantly associated with
TB. Importantly, associations between any helminth co-infection and TB were reported in pre-
vious epidemiologic studies [21,36,37], as well as in experimental work using animal or
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Table 4. Associations of TB disease with helminth infection and other patient characteristics.
Characteristics Any helminth infection (n = 972) S. mansoni infection (n = 972)
TB patients Controls Adjusted Adjusted
n (%) n (%) aOR (95% CI) p-value aOR (95% CI) p-value
Helminth infection 0.22 0.040
No 407 (68.2) 278 (74.1) 1.00 1.00
Yes 190 (31.8) 97 (25.9) 1.26 (0.88–1.80) 2.15 (1.03–4.45)
Age group (years) 0.49 0.25
18–24 107 (17.9) 87 (23.2) 1.00 1.00
25–34 226 (37.9) 121 (32.3) 1.22 (0.77–1.94) 1.24 (0.78–1.97)
35–44 169 (28.3) 97 (25.9) 1.00 (0.60–1.67) 1.02 (0.61–1.7)
45 95 (15.9) 70 (18.7) 0.85 (0.48–1.48) 0.88 (0.51–1.54)
Sex <0.001 <0.001
Female 186 (31.2) 201 (53.6) 1.00 1.00
Male 411 (68.8) 174 (46.4) 3.12 (2.13–4.56) 3.16 (2.16–4.63)
HIV status <0.001 <0.001
Negative 434 (72.7) 340 (90.7) 1.00 1.00
Positive 163 (27.3) 35 (9.3) 6.18 (3.83–9.95) 6.23 (3.86–10.05)
Education level 0.55 0.57
No/primary 500 (83.8) 306 (81.6) 1.00 1.00
Secondary/University 97 (16.2) 69 (18.4) 1.15 (0.73–1.80) 1.14 (0.72–1.79)
Employment status 0.63 0.66
Unemployed 204 (34.2) 145 (38.7) 1.00 1.00
Employed 393 (65.8) 230 (61.3) 0.91 (0.62–1.33) 0.92 (0.63–1.34)
Smoking status 0.012 0.011
No 489 (81.9) 342 (91.2) 1.00 1.00
Yes 108 (18.1) 33 (8.8) 1.92 (1.15–3.21) 1.95 (1.16–3.25)
Number of people in the household 0.018 0.015
3 people 442 (74.0) 289 (77.1) 1.00 1.00
>3 people 155 (26.0) 86 (22.9) 1.58 (1.08–2.30) 1.60 (1.09–2.34)
Household income per month (US$) 0.85 0.95
100 473 (79.2) 290 (77.3) 1.00 1.00
>100 124 (20.8) 85 (22.7) 1.04 (0.69–1.56) 1.01 (0.68–1.52)
BMI category (kg/m2) <0.001 <0.001
BMI18 279 (46.7) 318 (53.3) 1.00 1.00
BMI <18 356 (94.9) 19 (5.1) 23.20 (13.91–38.69) 23.52 (14.1–39.24)
Occupational riska 0.24 0.26
No 322 (54.2) 199 (54.1) 1.00 1.00
Yes 272 (45.8) 169 (45.9) 0.82 (0.59–1.15) 0.83 (0.59–1.15)
Individual deworming (past 12 months) 0.20 0.21
Yes 484 (81.1) 313 (83.5) 1.00 1.00
No 113 (18.9) 62 (16.5) 0.75 (0.48–1.16) 0.76 (0.49–1.17)
BMI, body mass index; CI, confidence interval; HIV, human immunodeficieny virus; OR, odds ratio; US$, United States dollars (1 US$ = 2,190 Tanzanian
Shillings in March 2016)
a Occupational risk for acquiring schistosomiasis (working in rice fields, sand harvesting, washing cars, and fishing)
Logistic regression model for TB disease status as the outcome. Model adjusted for any helminth infection/S. mansoni, age, sex, HIV status, BMI, education
level, employment status, smoking status, number of people living in the same household, individual deworming status, helminth risk occupation and
income level.
The full table with unadjusted and adjusted odds ratios is shown in the Supplementary Information (S7 Table).
doi:10.1371/journal.pntd.0005342.t004
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Table 5. Patient characteristics of TB patients infected and not infected with helminths at the time of TB diagnosis.
Characteristics Total TB and helminth TB only p-value
(n = 597) (n = 190) (n = 407)
Age, median (IQR) (years) 33 (26–40) 31 (26–39) 34 (27–40) 0.22
Age groups (years) 0.13
18–24 107 (17.9) 35 (18.4) 72 (17.7)
25–34 226 (37.9) 81 (42.6) 145 (35.6)
35–44 169 (28.3) 42 (22.1) 127 (31.2)
45 95 (15.9) 32 (16.8) 63 (15.5)
Sex 0.007
Female 186 (31.2) 45 (23.7) 141 (34.6)
Male 411 (68.8) 145 (76.3) 266 (65.4)
HIV status 0.003
Negative 434 (72.7) 153 (80.5) 281 (69.0)
Positive 163 (27.3) 37 (19.5) 126 (31.0)
CD4+ count, cells/mla 202 (94–273) 185 (90–259) 203 (100–273) 0.74
Education level 0.49
No/primary 500 (83.8) 162 (85.3) 338 (83.0)
Secondary/University 97 (16.2) 28 (14.7) 69 (17.0)
Occupation 0.99
Unemployed 204 (34.2) 65 (34.2) 139 (34.2)
Employed 393 (65.8) 125 (65.8) 268 (65.8)
Number of people in the household 0.89
3 people 442 (74.0) 140 (73.7) 302 (74.2)
> 3 people 155 (26.0) 50 (26.3) 105 (25.8)
Smoking status <0.004
No 489 (81.9) 143 (75.3) 346 (85.0)
Yes 108 (18.1) 47 (24.7) 61 (15.0)
Household income per month (US$) 0.45
100 473 (79.2) 154 (81.1) 319 (78.4)
>100 124 (20.8) 36 (18.9) 88 (21.6)
Body weight (kg), median (IQR) 51 (46–57) 50.9 (46–56) 51.7 (46–57.5) 0.40
BMI (kg/m2), median(IQR) 18.3 (16.6–20.4) 18.2 (16.5–20.2) 18.5 (16.6–20.4) 0.22
BMI (kg/m2) groups, n (%) 0.40b
Underweight <18.5 318 (53.3) 108 (56.8) 210 (51.6)
Normal, 18.5–24.9 256 (42.9) 78 (41.1) 178 (43.7)
Overweight 25.0–29.9 21 (3.5) 4 (2.1) 17 (4.2)
Obese30 2 (0.3) 0 2 (0.5)
Body fat (%) 9.5 (6.8–13.7) 9.1 (6.0–12.7) 9.8 (7.4–14.0) 0.008
MUAC (cm), median (IQR) 23.3 (22.0–25.3) 23.7 (22.0–25.0) 23.3 (22.0–25.7) 0.99
Waist hip ratio, median (IQR) 0.89 (0.85–0.94) 0.89 (0.85–0.94) 0.89 (0.86–0.94) 0.75
Occupational risk 0.095
No 322 (54.2) 93 (49.2) 229 (56.5)
Yes 272 (45.8) 96 (50.8) 176 (43.5)
Individual deworming (past 12 months) 0.013
Yes 484 (81.1) 143 (75.3) 341 (83.8)
No 113 (18.9) 47 (24.7) 66 (16.2)
Symptomsc
Cough 594 (99.5) 189 (99.5) 405 (99.5) 0.96
Fever 551 (92.3) 174 (91.6) 377 (92.6) 0.65
(Continued )
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macrophage infection models [9,13,15]. In line with our findings, a recent study with human
peripheral mononuclear cells exposed to M. tuberculosis and S. mansoni antigens showed that
S. mansoni-induced CD4+ T cells disrupt the control of M. tuberculosis in infected macro-
phages [9].
Several studies in humans suggested that helminth infections may increase the risk for pro-
gression of latent M. tuberculosis infection to active TB [15,21,37] as well as for exacerbating
the disease [15]. However, the results of these studies are conflicting, and no differentiation at
the helminth species level was made in these analyses. Indeed, the hypothesis of a helminth
species-specific impact on the host response is supported by a recent systematic review, which
revealed a trend toward an association between a decrease in HIV viral loads and treatment
for S. mansoni, but not for other helminth species [38]. A case-control study from Ethiopia
also found an association between TB and helminth infections, and the association was stron-
ger in patients that were infected with multiple helminth species [21]. The small number of
study participants with S. mansoni infection (31 among TB cases, nine among controls) may
have masked an association between TB and schistosomiasis in that study [21]. In contrast, a
cohort study from India showed no difference in TB incidence rates in helminth-infected and
helminth-free individuals after 2.5 years of follow-up [39].
We also found that S. mansoni, but not other helminth species, was associated with the clin-
ical presentation among TB patients. Patients co-infected with S. mansoni had lower sputum
bacterial loads at the time of TB diagnosis than S. mansoni-negative TB patients. Similarly, a
study in Ethiopia observed lower sputum bacterial loads at TB diagnosis in TB patients co-
infected with any helminth species [40]. Interestingly, our observation in TB patients co-
infected with S. mansoni resembles the paucibacillary disease in HIV-positive individuals with
severe immunosuppression, who frequently have negative or low bacterial M. tuberculosis
Table 5. (Continued)
Characteristics Total TB and helminth TB only p-value
(n = 597) (n = 190) (n = 407)
Weight loss 573 (96.0) 181 (95.3) 392 (96.3) 0.54
Night sweats 566 (94.8) 184 (96.8) 382 (93.9) 0.13
Hemoptysis 197 (33.0) 74 (38.9) 123 (30.2) 0.035
TB score, median (IQR) 5 (4–6) 5 (4–6) 5 (4–6) 0.22
TB score (0–5) 372 (62.3) 115 (60.5) 257 (63.1)
TB score (6–12) 225 (37.7) 75 (39.5) 150 (36.9)
TB treatment categories 0.40
Retreatment 14 (2.3) 3 (1.6) 11 (2.7)
New patients 583 (97.7) 187 (98.4) 396 (97.3)
Blood parameters c
Hemoglobin level 11.3 (9.9–12.7) 11.7 (10.1–13) 11.3 (9.8–12.5) 0.044
Eosinophil, cells per μld 0.15 (0.06–0.32) 0.2 (0.1–0.4) 0.1 (0.05–0.2) 0.003
AFB, acid-fast bacilli; BMI, body mass index; HIV, human immunodefiency virus; IQR, interquartile range; MUAC, mid-upper arm circumference; US$,
United States dollars (1 US$ = 2,190 Tanzanian Shillings in March 2016)
Helminth infection occupation risk (working in rice fields, sand harvesting, washing cars, and fishing)
a TB patient co-infected with HIV and have CD4+ count values (n = 80)
b Fisher’s exact test
c
“Symptoms”, and “blood parameters”: categories not mutually exclusive
d TB patients with an available full blood count result (n = 322)
doi:10.1371/journal.pntd.0005342.t005
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loads in the sputum compared with HIV-negative patients [40,41]. Hence, the helminth-
induced Th1 immunological impairment might have an effect on the sputum bacterial load.
Moreover, TB patients with an impaired host immune system rarely present with lung cavita-
tion resulting in fewer M. tuberculosis bacilli being expectorated in the sputum [40,41]. This is
in line with our findings that TB patients co-infected with S. mansoni tended to present less
frequently with lung cavitations compared with S. mansoni-negative TB patients. Any hel-
minth co-infection did not appear to have an effect on clinical outcomes during follow-up. We
found no evidence for an effect of helminth co-infection on the gain in the percentage of body
fat and BMI after 6 months (e.g., at the time of completed TB treatment). This might be
explained by the fact that the administration of anthelmintic treatment offered to the study
participants after diagnosis might have reversed the Th1 immune response [15], and thus
attenuated the effect of helminth infections on clinical outcomes. However, the effect of a
reversal of the Th1 immune response could be minimal as the anthelmintic drugs target the
worms [42], which are less immunogenic compared with deposited S. mansoni eggs [9].
We found that TB patients had a higher crude prevalence of helminth infections, as com-
pared with household contact controls. The higher prevalence of helminth infections among
TB patients could be the result of the pathogenic role of helminth infection in the progression
from M. tuberculosis infection to active TB. The higher prevalence of helminth co-infection in
TB patients has also been noted in other studies from different settings [9,43]. For example,
a study conducted in Ethiopia reported a higher prevalence of helminth infection among
TB patients as compared with household contact controls [21]. Overall, the prevalence of
Table 6. Effect of helminth infection on the clinical severity and clinical presentation in TB patients at the time of TB diagnosis.
Helminth infection Severe TB scorea High sputum bacterial
loadb
Lung infiltration Lung cavitation
aOR (95% CI) p-value aOR (95% CI) p-value aOR (95% CI) p-value aOR (95% CI) p-value
Any helminth infection 0.55 0.12 0.42 0.82
No 1.00 1.00 1.00 1.00
Yes 1.12 (0.78–1.61) 0.75 (0.51–1.08) 0.82 (0.50–1.33) 0.95 (0.60–1.50)
Strongyloides stercoralisc 0.44 0.39 0.17 0.76
No 1.00 1.00 1.00 1.00
Yes 1.19 (0.76–1.86) 0.82 (0.52–1.29) 1.56 (0.83–2.92) 1.09 (0.62–1.91)
Schistosoma mansoni d 0.75 0.004 0.15 0.088
No 1.00 1.00 1.00 1.00
Yes 0.89 (0.45–1.78) 0.37 (0.19–0.72) 0.51 (0.21–1.27) 0.41 (0.12–1.16)
Hookworme 0.55 0.40 0.086 0.54
No 1.00 1.00 1.00 1.00
Yes 1.20 (0.67–2.15) 0.77 (0.42–1.42) 0.51 (0.23–1.10) 0.79 (0.37–1.69)
Multiple infections 0.82 0.020 0.19 0.40
None 1.00 1.00 1.00 1.00
Mono 1.13 (0.77–1.67) 0.88 (0.59–1.31) 0.85 (0.51–1.43) 1.06 (0.66–1.72)
Double or more 1.04 (0.48–2.22) 0.34 (0.16–0.73) 0.67 (0.24–1.84) 0.50 (0.17–1.44)
Logistic regression model adjusted for age, sex, HIV infection, and smoking status.
a TB score (mild [score of 1–5] and severe [score of 6–12])
b Sputum bacterial load (according to qualitative AFB smear microscopy grading): mild (scanty and 1+) and severe (+2)
c 79 TB patients with any helminth infection other than S. stercoralis were excluded
d 150 TB patients with helminth co-infection other than S. mansoni were excluded
e 72 TB patients with helminth co-infection other than hookworm were excluded
doi:10.1371/journal.pntd.0005342.t006
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helminth infection in our study was 32% and lower compared with the 71% observed in the
latter study [21]. It is conceivable that the high proportion of self-reported previous use of
anthelmintic drugs in our study (approximately 80%) could have reduced the overall preva-
lence of helminth infection. Hence, we may have underestimated the effects of helminth infec-
tion seen in our study.
We also found that occupation exposing people to regular water contacts (for instance rice
field workers, sand harvesters, car washers, and fishermen) were associated with helminth
infections. Being exposed to freshwater bodies and being involved in water-related activities
have previously been reported to increase the risk of helminth infections [44]. In the current
study, HIV-positive individuals were less likely to be co-infected with helminths. A lower prev-
alence of helminth infections in HIV-positive patients has also been reported in a study con-
ducted in Mwanza in northern Tanzania, which is a highly endemic area for helminthiases
[45]. Of note, current clinical practice in Tanzania is to treat any helminth infection in HIV-
positive patients at enrolment into HIV care and in case of clinical suspicion of helminth infec-
tion during follow-up, as specified in the HIV/AIDS management guideline [17]. The use of
anthelmintic drugs is safe and might be beneficial in HIV-positive patients by possibly reduc-
ing the HIV-RNA viral load and subsequently improving clinical outcomes [46]. Furthermore,
cotrimoxazole preventive therapy (CPT), which is recommended for HIV-positive patients,
has also been reported to have limited anthelmintic properties [43,47]. This might explain the
lower prevalence of helminth infection among HIV-positive individuals in our study [17].
Our research has several strengths and limitations that warrant consideration. An impor-
tant strength of our study is the large sample size and the recruitment of both TB patients and
household contact controls with similar socioeconomic profiles and exposure patterns to both
TB and helminth infection. Our findings may well apply to other settings with a similar preva-
lence of TB, HIV, and helminth infections in sub-Saharan Africa. Furthermore, we used rec-
ommended TB diagnostics and a suite of standardized, quality-controlled helminth
diagnostics, which have comparable diagnostic performance to resource-intensive molecular
test assays [25].
Study limitations include the following. First, this is an observational study which cannot
establish a causal relationship between helminth infections and TB disease. Second, we could
not fully verify whether or not the household contact controls were latently infected with
M. tuberculosis, which is a prerequisite to develop TB. However, because Dar es Salaam is a
high-burden setting for TB with considerable risk of transmission, and because living with a
TB patient is a strong risk factor for TB [35], it is reasonable to assume that the controls have
previously been exposed and infected with M. tuberculosis. Third, we did not check the hel-
minth infection status for TB patients during and after completion of TB treatment, which
could influence the clinical outcomes. However, we do not expect a high helminth re-infection
rate after 6 months in our study area [48]. Fourth, we did not use molecular diagnostics such
as polymerase chain reaction (PCR) which might have identified some more cases, but one of
our previous studies revealed that also PCR approaches miss in particular very light intensity
infections. Moreover, its performance and sensitivity vary with the helminth species under
examination [25]. Hence, also a PCR cannot be considered as the diagnostic gold-standard.
In conclusion, co-infection with S. mansoni, but not other helminth species, was found to
be an independent risk factor for active TB in our study and was associated with the clinical
presentation in TB patients. These findings suggest a role for S. mansoni, or helminth infection
in general, in immunomodulation of human TB. Treatment of helminth infections should be
considered in the clinical management of TB patients, and helminthiasis control/elimination
through preventive chemotherapy might prove to be useful as an additional component of TB
control programs. Further research is needed to establish the underlying mechanisms, and
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compare helminth-induced immune regulation by different helminth species. Prospective
cohort studies that evaluate the effect of preventive anthelmintic chemotherapy on the inci-
dence of M. tuberculosis infection and active TB could further help to understand the interac-
tion between these diseases at the population level. Helminthiasis control measures, in
combination with traditional TB control strategies, could potentially contribute to the global
efforts to reduce TB incidence by 80% until 2030, as stipulated in WHO’s ambitious End TB
Strategy [5].
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